EVALUATION OF LIPID-LOWERING THERAPY IN PATIENTS WITH DEFINITE DIAGNOSIS OF HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA IN LODZ

被引：0
|
作者：
Gorzelak-Pabis, P. [1 ]
Pawlos, A. [2 ]
Staciwa, Z. [1 ]
Krulikowska, A. [1 ]
Broncel, M. [1 ]
机构：
[1] Med Univ Lodz, Dept Internal Dis & Clin Pharmacol, Lab Tissue Immunopharmacol, Lodz, Poland
[2] Med Univ Lodz, Dept Internal Dis & Clin Pharmacol, Lab Tissue Immunopharmacol, Lodz, Poland
来源：
ATHEROSCLEROSIS | 2022年 / 355卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
EP409
引用
收藏
页码：E225 / E226
页数：2
相关论文
共 50 条
  • [41] Effect of lipid-lowering treatment in cardiovascular disease prevalence in familial hypercholesterolemia
    Perez-Calahorra, Sofia
    Laclaustra, Martin
    Marco-Benedi, Victoria
    Lamiquiz-Moneo, Itziar
    Pedro-Botet, Juan
    Plana, Nuria
    Sanchez-Hernandez, Rosa M.
    Amor, Antonio J.
    Almagro, Fatima
    Fuentes, Francisco
    Suarez-Tembra, Manuel
    Civeira, Fernando
    ATHEROSCLEROSIS, 2019, 284 : 245 - 252
  • [42] Plant sterol supplementation on top of lipid-lowering therapies in familial hypercholesterolemia
    Izar, M. C.
    Machado, V. A.
    Fonseca, H. A.
    Fonseca, F. A.
    EUROPEAN HEART JOURNAL, 2015, 36 : 285 - 285
  • [43] LDL cholesterol target achievement in heterozygous familial hypercholesterolemia patients according to 2019 ESC/EAS lipid guidelines: Implications for newer lipid-lowering treatments
    Rizos, Christos V.
    Skoumas, Ioannis
    Rallidis, Loukianos
    Skalidis, Emmanouil
    Tziomalos, Konstantinos
    Garoufi, Anastasia
    Anagnostis, Panagiotis
    Sfikas, George
    Kotsis, Vasileios
    Doumas, Michalis
    Kolovou, Genovefa
    Lambadiari, Vaia
    Dima, Ioanna
    Kiouri, Estela
    Zacharis, Evangelos
    Agapakis, Dimitrios
    Attilakos, Achilleas
    Antza, Christina
    Vlachopoulos, Charalambos
    Liberopoulos, Evangelos N.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2021, 345 : 119 - 124
  • [44] Plant sterol supplementation on top of lipid-lowering therapies in familial hypercholesterolemia
    Machado, Valeria A.
    Fonseca, Francisco A.
    Fonseca, Henrique A.
    Malina, Daniela T.
    Fonzar, Waleria T.
    Barbosa, Silvio A.
    Santana, Jose M.
    Izar, Maria C.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2015, 184 : 570 - 572
  • [45] Lomitapide and Mipomersen Novel Lipid-Lowering Agents for the Management of Familial Hypercholesterolemia
    Dixon, Dave L.
    Sisson, Evan M.
    Butler, Michael
    Higbea, Ashley
    Muoio, Brendan
    Turner, Brandy
    JOURNAL OF CARDIOVASCULAR NURSING, 2014, 29 (05) : E7 - E12
  • [46] Use and persistence of lipid-lowering therapy in patients with severe hypercholesterolemia: A prospective study
    Matta, Maria G.
    Saenz, Benjamin
    Schreier, Laura
    Corral, Agustina
    Sarobe, Agustina
    Corral, Pablo
    CLINICA E INVESTIGACION EN ARTERIOSCLEROSIS, 2021, 33 (06): : 308 - 313
  • [47] Lipid-Lowering Effect of Nattokinase in Patients with Primary Hypercholesterolemia
    Wu, Der-Jinn
    Lin, Cheng-Sheng
    Lee, Ming-Yung
    ACTA CARDIOLOGICA SINICA, 2009, 25 (01) : 26 - 30
  • [48] Lipoprotein(a) levels and cholesterol efflux capacity: inverse association and impact on atherosclerosis in familial hypercholesterolemia patients on lipid-lowering therapy
    Ogura, M.
    Matsuki, K.
    Kataoka, Y.
    Funabashi, S.
    Harada-Shiba, M.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [49] Randomized Evaluation of Anacetrapib Lipid-Modifying Therapy in Patients With HeteroZygous Familial HypercholesterolEmia (REALIZE Study)
    Kastelein, John J.
    Besseling, Joost
    Shah, Sukrut
    Bergeron, Jean
    Langslet, Gisle
    Hovingh, G. Kees
    Al-Saady, Naab
    Koeijvoets, Michiel
    Hunter, John
    Johnson-Levonas, Amy O.
    Fable, Jennifer
    Sapre, Aditi
    Mitchel, Yale
    CIRCULATION, 2014, 130
  • [50] NUMBER OF LIPID-LOWERING MEDICATIONS AND ATTAINMENT OF LIPID GOALS IN FAMILIAL HYPERCHOLESTEROLEMIA PATIENTS: DATA FROM THE LATVIAN REGISTRY
    Nesterovics, G.
    Saripo, V.
    Meiere, R.
    Terauda, E.
    Skudrina, G.
    Gilis, D.
    Erglis, A.
    Latkovskis, G.
    ATHEROSCLEROSIS, 2022, 355 : E176 - E176
12345